158 related articles for article (PubMed ID: 21157300)
21. Carbon monoxide releasing molecule-2 improves coagulation in patient plasma in vitro following cardiopulmonary bypass.
Malayaman SN; Entwistle JW; Boateng P; Wechsler AS; Persaud JM; Cohen JB; Kirklin JK; Nielsen VG
Blood Coagul Fibrinolysis; 2011 Jul; 22(5):362-8. PubMed ID: 21346555
[TBL] [Abstract][Full Text] [Related]
22. Carbon monoxide releasing molecule enhances coagulation and decreases fibrinolysis in canine plasma exposed to Crotalus viridis venom in vitro and in vivo.
Johnson TE; Wells RJ; Bell A; Nielsen VG; Olver CS
Basic Clin Pharmacol Toxicol; 2019 Oct; 125(4):328-336. PubMed ID: 31059181
[TBL] [Abstract][Full Text] [Related]
23. Carbon monoxide releasing molecule-2 increases fibrinogen-dependent coagulation kinetics but does not enhance prothrombin activity.
Nielsen VG; Malayaman SN; Khan ES; Kirklin JK; George JF
Blood Coagul Fibrinolysis; 2010 Jun; 21(4):349-53. PubMed ID: 20449889
[TBL] [Abstract][Full Text] [Related]
24. Fibrinogen is a heme-associated, carbon monoxide sensing molecule: a preliminary report.
Nielsen VG; Cohen JB; Malayaman SN; Nowak M; Vosseller K
Blood Coagul Fibrinolysis; 2011 Jul; 22(5):443-7. PubMed ID: 21451399
[TBL] [Abstract][Full Text] [Related]
25. Iron and carbon monoxide attenuate Crotalus atrox venom-enhanced tissue-type plasminogen activator-initiated fibrinolysis.
Nielsen VG; Boyer LV; Matika RW; Amos Q; Redford DT
Blood Coagul Fibrinolysis; 2016 Jul; 27(5):511-6. PubMed ID: 26575490
[TBL] [Abstract][Full Text] [Related]
26. Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
Kramkowski K; Leszczynska A; Mogielnicki A; Chlopicki S; Fedorowicz A; Grochal E; Mann B; Brzoska T; Urano T; Motterlini R; Buczko W
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2149-57. PubMed ID: 22772756
[TBL] [Abstract][Full Text] [Related]
27. Redox-based thrombelastographic method to detect carboxyhemefibrinogen-mediated hypercoagulability.
Nielsen VG; Arkebauer MR; Vosseller K
Blood Coagul Fibrinolysis; 2011 Dec; 22(8):657-61. PubMed ID: 21822126
[TBL] [Abstract][Full Text] [Related]
28. Protamine enhances fibrinolysis by decreasing clot strength: role of tissue factor-initiated thrombin generation.
Nielsen VG
Ann Thorac Surg; 2006 May; 81(5):1720-7. PubMed ID: 16631662
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the effects of CORM-2, CORM-3 and CORM-A1 on coagulation in human plasma.
Nielsen VG; Garza JI
Blood Coagul Fibrinolysis; 2014 Dec; 25(8):801-5. PubMed ID: 25058038
[TBL] [Abstract][Full Text] [Related]
30. High-molecular-weight hydroxyethyl starch accelerates kallikrein-dependent clot initiation.
Nielsen VG
J Trauma; 2007 Jun; 62(6):1491-4. PubMed ID: 17563672
[TBL] [Abstract][Full Text] [Related]
31. Thrombelastographic characterization of coagulation/fibrinolysis in horses: role of carboxyheme and metheme states.
Olver CS; Nielsen VG
Blood Coagul Fibrinolysis; 2013 Apr; 24(3):273-8. PubMed ID: 23222168
[TBL] [Abstract][Full Text] [Related]
32. Southern copperhead venom enhances tissue-type plasminogen activator induced fibrinolysis but does not directly lyse human plasma thrombi.
Nielsen VG
J Thromb Thrombolysis; 2016 Jul; 42(1):33-7. PubMed ID: 26407681
[TBL] [Abstract][Full Text] [Related]
33. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor.
von dem Borne PA; Cox LM; Bouma BN
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866
[TBL] [Abstract][Full Text] [Related]
34. Carbon monoxide and nitric oxide modulate α₂-antiplasmin and plasmin activity: role of heme.
Arkebauer MR; Kanaparthy SS; Malayaman SN; Vosseller K; Nielsen VG
Blood Coagul Fibrinolysis; 2011 Dec; 22(8):712-9. PubMed ID: 22024794
[TBL] [Abstract][Full Text] [Related]
35. Elastic modulus-based thrombelastographic quantification of plasma clot fibrinolysis with progressive plasminogen activation.
Nielsen VG; Cohen BM; Cohen E
Blood Coagul Fibrinolysis; 2006 Jan; 17(1):75-81. PubMed ID: 16607085
[TBL] [Abstract][Full Text] [Related]
36. Effects of Hextend hemodilution on plasma coagulation kinetics in the rabbit: role of factor XIII-mediated fibrin polymer crosslinking.
Nielsen VG
J Surg Res; 2006 May; 132(1):17-22. PubMed ID: 16154147
[TBL] [Abstract][Full Text] [Related]
37. Clot life span model analysis of clot growth and fibrinolysis in normal subjects: role of thrombin activatable fibrinolysis inhibitor.
Nielsen VG
Blood Coagul Fibrinolysis; 2008 Jun; 19(4):283-7. PubMed ID: 18469549
[TBL] [Abstract][Full Text] [Related]
38. Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.
Jankun J; Aleem AM; Selman SH; Skrzypczak-Jankun E; Lysiak-Szydlowska W; Grafos N; Fryer HJ; Greenfield RS
Int J Mol Med; 2007 Nov; 20(5):683-7. PubMed ID: 17912461
[TBL] [Abstract][Full Text] [Related]
39. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
[TBL] [Abstract][Full Text] [Related]
40. Contact activation prolongs clot lysis time in human plasma: role of thrombin-activatable fibrinolysis inhibitor and Factor XIII.
Nielsen VG; Steenwyk BL; Gurley WQ
J Heart Lung Transplant; 2006 Oct; 25(10):1247-52. PubMed ID: 17045938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]